This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SLOAN J. WILSON, M.D.

Arch Intern Med. 1942;69(4):647-661.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The failure of the circulating blood to clot spontaneously under physiologic conditions in vivo still remains a unique and obscure phenomenon, since all of the elements essential for immediate coagulation in vitro are apparently present. Howell, in his fundamental concept of blood coagulation, has consistently maintained in at least partial explanation of this enigma that substances acting as clotting inhibitors are normally present in blood plasma. With the identification of heparin by Howell and Holt¹ and the demonstration of the presence of proantithrombin, the nature and role of these anticoagulants in the blood began to be better understood. Evidence has been presented suggesting that the principal anticoagulant effect of heparin is the prevention of the conversion of prothrombin to thrombin. However, when added to plasma, heparin apparently activates the proantithrombin, resulting in a tremendous increase in antithrombic activity. Charles and Scott,² among others, have confirmed the presence of . . . [Full Text PDF of this Article]

Author Affiliations
COLUMBUS, OHIO

From the Departments of Pathology and Medicine, Ohio State University.

Footnotes
This investigation was aided by a grant from the Comly Research Fund, Ohio State University.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?